{
    "2018-02-26": [
        [
            {
                "time": "2018-01-03",
                "original_text": "Biogen's Multiple Sclerosis Drug Franchise Takes Another Hit",
                "features": {
                    "keywords": [
                        "Biogen",
                        "Multiple Sclerosis",
                        "Drug Franchise",
                        "Hit"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "What’s Expected for Novo Nordisk’s Net Income Margin in 2018",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Net Income Margin",
                        "Expected"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "7 Europe Dividend ETFs for Overseas Income",
                "features": {
                    "keywords": [
                        "Europe",
                        "Dividend ETFs",
                        "Overseas Income"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "Novo Nordisk Expected to Report Flat Revenue in 2018",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Flat Revenue",
                        "Expected"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-07",
                "original_text": "Analysts’ Recommendations for Novo Nordisk and Peers in 2018",
                "features": {
                    "keywords": [
                        "Analysts",
                        "Recommendations",
                        "Novo Nordisk",
                        "Peers"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-08",
                "original_text": "Johnson & Johnson’s Oncology Segment’s Performance in 2017",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Oncology Segment",
                        "Performance",
                        "2017"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-09",
                "original_text": "The Swiss Stock Market Climbed Back Above 9,000 Points",
                "features": {
                    "keywords": [
                        "Swiss Stock Market",
                        "Climbed",
                        "9,000 Points"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}